Providing more than 200 human primary cell types
Lonza BioScience provides research tools and instruments supporting the preclinical and clinical pharmaceutical value chain including drug discovery and ADMETox. Our integrated portfolio of primary cells, including liver, kidney, skin, lung, and neural cells allows development of the next generation of predictive in vitro ADMETox solutions.